Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation
- Resource Type
- article
- Source
- Nature Communications, Vol 14, Iss 1, Pp 1-17 (2023)
- Subject
Science - Language
- English
- ISSN
- 2041-1723